# A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin

> **NCT01756495** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 56 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Losmapimod
- **DRUG:** Moxifloxacin
- **DRUG:** Losmapimod matched Placebo
- **DRUG:** Moxifloxacin Placebo

## Key facts

- **NCT ID:** NCT01756495
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-10
- **Primary completion:** 2013-04-23
- **Final completion:** 2013-04-23
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01756495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01756495, "A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01756495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*